• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7
2
2
2
1

COUNTRY

2
1

CATEGORIES

  • 11
  • 8
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

19
19
22
27

PUBLISHED

0
2
8
27

PRODUCT TYPE

18
9

Search "Par Pharmaceutical Companies, Inc. - SWOT Analysis" returned 27 results.

Par Pharmaceutical Companies, Inc. - Strategic SWOT Analysis Review

Par Pharmaceutical Companies, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains...

April 2015
FROM

Par Pharmaceutical Companies Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Par Pharmaceutical Companies Inc. Company Profile” is a comprehensive report on Par Pharmaceutical Companies Inc.. The report provides complete information on the operations, organization structure...

October 2014
FROM

Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review

Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review Summary Par Pharmaceutical Companies, Inc. (Par Pharmaceutical) is a publicly traded pharmaceutical company....

March 2012
FROM

Par Pharmaceutical Companies, Inc.: Company Profile and SWOT Analysis

Synopsis ICD Research's "Par Pharmaceutical Companies, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company...

December 2011
FROM

Par Pharmaceutical Companies, Inc.: SWOT Analysis & Company Profile

Synopsis Business Review’s Par Pharmaceutical Companies, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This...

April 2010
FROM

Par Pharmaceutical Companies, Inc. - Strategy and SWOT Report

Par Pharmaceutical Companies, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product...

October 2014
FROM

Global Generic Drugs Market 2014-2018

The analysts forecast the Global Generic Drugs market to grow at a CAGR of 11 02 percent over the period 2013-2018 The patent expiry of top-selling drugs is one of the major drivers contributing to...

March 2014
FROM

Auxilium Pharmaceuticals, Inc. (AUXL) - Financial and Strategic SWOT Analysis Review

Auxilium Pharmaceuticals, Inc. (AUXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

April 2014
FROM

North American Air Compressor Market (Type, Product Design, Lubrication Method, and Countries) - Size, Share, Global Trends, Company Profiles, Analysis, Segmentation and Forecast, 2013 -2020

In the North American market, air compressors primarily find application in industries such as food and beverage, oil extraction, and pharmaceutical. The emergence of energy-efficient portable air compressors...

December 2014
FROM

Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report

Synopsis ICD Research's "Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report" contains in depth information and data about the company and its operations....

April 2013
FROM

Catalyst Pharmaceutical Partners, Inc. (CPRX) - Financial and Strategic SWOT Analysis Review

Catalyst Pharmaceutical Partners, Inc. (CPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile...

June 2015
FROM

Mylan Inc. (MYL) - Financial and Strategic SWOT Analysis Review

Mylan Inc. (MYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

May 2014
FROM

Lannett Company, Inc. (LCI) - Financial and Strategic SWOT Analysis Review

Lannett Company, Inc. (LCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

January 2014
FROM

Prefilled Syringes Market (3rd Edition), 2015 - 2025

Injectable drug delivery systems have traversed a long way from conventional syringes with vials to prefilled syringes, auto-injectors, pen injectors and needle free systems. These modern devices have...

June 2015
FROM

Columbia Laboratories Inc. (CBRX) - Financial and Strategic SWOT Analysis Review

Columbia Laboratories Inc. (CBRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Oral Thin Films Market, 2015 - 2025

Oral drug delivery technologies form an integral part of the pharmaceutical industry. From the conventional tablets / capsules to modern-day fast disintegrating and rapidly acting tablets / films, the...

January 2015
FROM

Analyzing the Global Generics Industry 2014

In recent times there has been a growing focus on the generic drugs industry worldwide The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the...

August 2014
FROM

Par Pharmaceutical Companies, Inc. - Company PicShot

This Company PicShot is a brief, yet detailed, profile of the chosen company. The PicShot profiles the company in terms of historical background, company overview, business segment analysis, a view...

November 2010
FROM

KV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review

KV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review Summary KV Pharmaceutical Company (KV Pharmaceutical) is a specialty pharmaceutical company engaged in the development,...

September 2011
FROM

Santarus, Inc. (SNTS) - Financial and Strategic SWOT Analysis Review

Summary Santarus, Inc. (Santarus) is a specialty biopharmaceutical company. It acquires, develops and commercializing pharmaceutical products. The company’s marketed products consists of Uceris (budesonide)...

March 2013
FROM
Loading Indicator

Our Clients

Intel Corporation Autodesk, Inc. Hewlett-Packard Company Ahlstrom Corporation SAP SE 3M Company Samsung Group Ltd.